DiaSorin launches the new LIAISON® QUANTIFERON®-TB GOLD PLUS ASSAY as an aid for latent tuberculosis


DiaSorin  and QIAGEN® N.V. today announced the launch in the CE market of the LIAISON® QuantiFERON®-TB Gold Plus as an aid to detect latent tuberculosis infection (LTBI) on LIAISON® analyzer systems. The new test was developed in a partnership between DiaSorin and QIAGEN®.